NCT06138613Phase 3Active not recruiting

Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Study sponsor: Vanda Pharmaceuticals

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2027-09-30Estimated
Enrollment · participants705Actual
Source updated2026-04-16Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date

Recorded edit
− Previous value

2026-05-30

+ Updated value

2027-09-30

Check registry source

· 4 fields changed

Participant count type

Recorded edit
− Previous value

Estimated

+ Updated value

Actual

Enrollment · participant count

Recorded edit
− Previous value

count: 500; type: ESTIMATED

+ Updated value

count: 705; type: ACTUAL

Primary completion date

Recorded edit
− Previous value

2025-04-30

+ Updated value

2026-05-30

Recruitment status

Recorded edit
− Previous value

Recruiting

+ Updated value

Active not recruiting

Check registry source